Add like
Add dislike
Add to saved papers

Repeated Pre-exposure to Morphine Inhibited the Amnesic Effect of Ethanol on Spatial Memory: Involvement of CaMKII and BDNF.

Alcohol 2023 August 18
Evidence suggested that addiction and memory systems are related, but the signaling cascades underlying this interaction have not been ultimately revealed yet. The importance of Calcium-calmodulin-dependent protein kinase II (CaMKII) and Brain-derived neurotrophic factor (BDNF) in the memory processes and also in drug addiction have been previously established. In this present investigation, we examined the effects of repeated morphine pre-treatment on impairment of spatial learning and memory acquisition induced by systemic ethanol administration in adult male rats. Also, we assessed how these drug-exposures influence the expression level of CAMKII and BDNF in the hippocampus and amygdala. Animals were trained by a single training session of eight trials, and a probe test containing 60 s free-swim without a platform was administered 24 h later. Before training trials, rats were treated with a once-daily subcutaneous morphine injection for three days followed by a 5-day washout period. The results showed that pre-training ethanol (1 g/kg) impaired spatial learning and memory acquisition and down-regulated the mRNA expression of CAMKII and BDNF. The amnesic effect of ethanol was suppressed in morphine (15 mg/kg/day) pre-treated animals. Furthermore, the mRNA expression level of CAMKII and BDNF increased significantly following ethanol administration in morphine-pretreated rats. Conversely, this improvement in spatial memory acquisition was prevented by daily subcutaneous administration of naloxone (2 mg/kg) 15 min prior to morphine. Our findings suggest that sub-chronic morphine treatment reverses ethanol-induced spatial memory impairment which could be explained by modulating CAMKII and BDNF mRNA expressions in the hippocampus and amygdala.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app